1) amino pyrimidine compounds
氨基嘧啶类化合物
1.
Based on B3LYP/6-311G* of DFT,the geometries of amino pyrimidine compounds were optimized,and then their visible absorption maxima were calculated with TD-DFT method and ZINDO/S method respectively.
对几种氨基嘧啶类化合物利用密度泛函的B3LYP/6-311G*进行构型优化,然后用TD-DFT方法和ZINDO/S方法分别计算了它们的最高吸收波长,结果与实验值较好吻合。
3) Pyrimidines
嘧啶类化合物
1.
An HPLC method for determination of five pyrimidines,such as 5-fluorouracil,5-bromouracil,5-iodouracil,sulfadiazine and sulfamethazine on diallyl trisulfide-bonded stationary phase(DTSP) was first developed by HPLC.
研究发现,大蒜新素固定相能较好地分离上述五种嘧啶类化合物,并用于模拟人尿液样品的定量分析。
4) pyridopyrimidine
吡啶并嘧啶类化合物
1.
Recent advances in the synthesis of pyridopyrimidine analogues were reviewed in this article in- cluding pyrido[2,3-d]pyrimidine, pyrido[1,2-a]pyrimidine and pyrido[4,3-d]pyrimidine analogues with 71 references.
综述了近二十年来吡啶并嘧啶类化合物的合成研究进展,介绍了三大类吡啶并嘧啶类化合物的主要结构类型:吡啶并[2,3-d]嘧啶类化合物、吡啶并[1,2-a]嘧啶类化合物、吡啶并[4,3-d]嘧啶类化合物的相关合成方法及新进展。
5) 2-(4,6-dimethoxy-pyrimidin-2-yloxy)-N-het/aryl-benzylamine derivatives
2-嘧啶氧基-N-芳基苄胺类化合物
1.
According to the result of biological experiments,2-(4,6-dimethoxy-pyrimidin-2-yloxy)-N-het/aryl-benzylamine derivatives were found to have the inhibiting activity of acetolactate synthase(ALS),and the relationship between these compounds and their activity was studied by 3D-QSAR:CoMFA and CoM-SIA.
生物活性测试结果表明,2-嘧啶氧基-N-芳基苄胺类化合物对ALS具有一定的抑制活性。
6) 6-(phenylthio) thymine HEPT analogues
6-苯硫基胸腺嘧啶类化合物
补充资料：氨基嘧啶
分子式：
CAS号：
性质：常见的如下。2-氨基嘧啶，针状结晶，熔点127～128℃，溶于水，盐酸盐熔点196℃，苦味酸盐熔点237～238℃。4-氨基嘧啶，片状结晶，熔点151～152℃，溶于水与乙醇。5-氨基嘧啶，熔点171～172℃。氨基处于嘧啶环的2位，4位，6位时，均可以亚氨基形式构成互变异构体。由相应的氯代嘧啶与氨反应制取。用作合成各种药物的中间体。
CAS号：
性质：常见的如下。2-氨基嘧啶，针状结晶，熔点127～128℃，溶于水，盐酸盐熔点196℃，苦味酸盐熔点237～238℃。4-氨基嘧啶，片状结晶，熔点151～152℃，溶于水与乙醇。5-氨基嘧啶，熔点171～172℃。氨基处于嘧啶环的2位，4位，6位时，均可以亚氨基形式构成互变异构体。由相应的氯代嘧啶与氨反应制取。用作合成各种药物的中间体。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条